1983
DOI: 10.1016/0006-8993(83)90880-6
|View full text |Cite
|
Sign up to set email alerts
|

Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of alzheimer-type patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
42
0

Year Published

1986
1986
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 169 publications
(46 citation statements)
references
References 50 publications
4
42
0
Order By: Relevance
“…These neurons have been electrophysiologically subdivided into several discrete categories: slow firing-firing neurons expressing wide action potentials and pronounced sAHP; fast-spiking neurons also expressing pronounced fast duration action potentials and fast AHP; regular firing neurons and burst firing neurons which were further classified as type I and II (Henderson et al, 2001). Immunohistochemical characterization revealed that slow firing neurons express markers of cholinergic neurons such as the acetylcholine (Ach) degradation enzyme acetylcholinesterase, Ach synthesizing enzyme choline acetyl transferase (ChAT) (Henke and Lang, 1983, Brashear et al, 1986, Griffith and Matthews, 1986, Gaykema et al, 1991 and p75, a specific growth factor receptor which is selectively expressed in basal forebrain cholinergic neurons (Hartig et al, 2002). In a recent study, whole-cell patch clamp combined with retrograde reverse transcriptase-polymerase chain reaction (RT-PCR) was used to determine the correlation of specific firing phenotypes with the expression of different mRNAs of enzymes synthesizing neurotransmitters (Sotty et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…These neurons have been electrophysiologically subdivided into several discrete categories: slow firing-firing neurons expressing wide action potentials and pronounced sAHP; fast-spiking neurons also expressing pronounced fast duration action potentials and fast AHP; regular firing neurons and burst firing neurons which were further classified as type I and II (Henderson et al, 2001). Immunohistochemical characterization revealed that slow firing neurons express markers of cholinergic neurons such as the acetylcholine (Ach) degradation enzyme acetylcholinesterase, Ach synthesizing enzyme choline acetyl transferase (ChAT) (Henke and Lang, 1983, Brashear et al, 1986, Griffith and Matthews, 1986, Gaykema et al, 1991 and p75, a specific growth factor receptor which is selectively expressed in basal forebrain cholinergic neurons (Hartig et al, 2002). In a recent study, whole-cell patch clamp combined with retrograde reverse transcriptase-polymerase chain reaction (RT-PCR) was used to determine the correlation of specific firing phenotypes with the expression of different mRNAs of enzymes synthesizing neurotransmitters (Sotty et al, 2003).…”
Section: Discussionmentioning
confidence: 99%
“…The administration of scopola mine, a muscarinic acetylcholine receptor antagonist, produces amnesic effects (21 23), while cholinergic drugs, including muscarinic agonists and acetylcholinesterase inhibitors, accelerate learning and memory in both hu mans and animals (22,24,25). The most strik ing and consistent change in AD and SDAT is in the cholinergic system, as measured by a marked decrease in choline acetyltransferase activity in the hippocampus and cerebral cor tex (8,9). These findings have drawn atten tion to the cholinergic system as a possible site for therapy of the dementing disorders.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, neuronal loss and a great number of neuro fibrillary tangles and senile plaques have been found in the hippocampus of patients with Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT) (6,7). In the hippocampal formation, there are also marked reductions in the activity of choline acetyl transferase, the enzyme that synthesizes acetyl choline, in these pathological states (8,9). In light of the role of the hippocampus in mem ory, these changes are likely to contribute to the memory deficits seen in AD and SDAT patients.…”
mentioning
confidence: 99%
“…65 Rossor et al and Henke and Lang reported that the brains of patients with AD showed the degeneration of cholinergic neurons and a reduction in cholinergic markers, whereas the activities of choline acetyltransferase (ChAT) and AChE were reduced in the cerebral cortexes of patients with AD. 66,67 A study reported by Soininen et al showed that AD patients carrying the apolipoprotein E (APOE) ε4 allele have a more severe cholinergic deficit than the AD patients without the APOE ε4 allele. 68 Phospholipase A2 (PA2) is the enzyme responsible for the synthesis of chemical mediators of inflammation and is also responsible for the conversion of phosphatidylcholine to choline.…”
Section: Ad Pathophysiologymentioning
confidence: 99%